Evidence map›Paper›PMID 30131474›Full record

ArticleInternational journal of molecular sciences2018

Aldehyde Dehydrogenase 2 (ALDH2) in Rat Fatty Liver Cold Ischemia Injury.

Arnau Panisello-Roselló, Norma Alva, Marta Flores, Alexandre Lopez, Carlos Castro Benítez, Emma Folch-Puy, Anabela Rolo, Carlos Palmeira, René Adam, Teresa Carbonell and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. The Role of IGL-2 Preservation Solution on Rat Livers during SCS and HOPE.International journal of molecular sciences · 2022
    Article
  10. Review
  11. Review
  12. Review
  13. PEG35 as a Preconditioning Agent against Hypoxia/Reoxygenation Injury.International journal of molecular sciences · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Molecular Mechanisms and Pathophysiology of Ischemia-Reperfusion Injury.International journal of molecular sciences · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Arnau Panisello-RosellóExperimental Hepatic Ischemia-Reperfusion Unit, Institut d'Investigacions Biomèdiques de Barcelona (IIBB), Spanish National Research Council (CSIC), 08036 Barcelona, Catalonia, Spain. arnau.panisello.rosello@gmail.com.ORCID 0000-0003-2062-6134
Norma AlvaDepartment of Cell Biology, Physiology and Immunology, Faculty of Biology, Universitat de Barcelona, 08028 Barcelona, Catalonia, Spain. nvalva@ub.edu.
Marta FloresDepartment of Cell Biology, Physiology and Immunology, Faculty of Biology, Universitat de Barcelona, 08028 Barcelona, Catalonia, Spain. mfloreso10@alumnes.ub.edu.
Alexandre LopezCentre Hépato-Biliaire, AP-PH, Hôpital Paul Brousse, 94800 Paris, France. alexandregl.lopez@gmail.com.ORCID 0000-0001-8978-4486
Carlos Castro BenítezCentre Hépato-Biliaire, AP-PH, Hôpital Paul Brousse, 94800 Paris, France. ccastrob@gmail.com.ORCID 0000-0001-5040-5960
Emma Folch-PuyExperimental Hepatic Ischemia-Reperfusion Unit, Institut d'Investigacions Biomèdiques de Barcelona (IIBB), Spanish National Research Council (CSIC), 08036 Barcelona, Catalonia, Spain. emma.folch@iibb.csic.es.
Anabela RoloCenter for Neurosscience and Cell Biology, Universidade de Coimbra, 300-370 Coimbra, Portugal. anpiro@ci.uc.pt.
Carlos PalmeiraCenter for Neurosscience and Cell Biology, Universidade de Coimbra, 300-370 Coimbra, Portugal. palmeira@uc.pt.
René AdamCentre Hépato-Biliaire, AP-PH, Hôpital Paul Brousse, 94800 Paris, France. rene.adam@aphp.fr.
Teresa CarbonellDepartment of Cell Biology, Physiology and Immunology, Faculty of Biology, Universitat de Barcelona, 08028 Barcelona, Catalonia, Spain. tcarbonell@ub.edu.ORCID 0000-0002-7131-3667
Joan Roselló-CatafauExperimental Hepatic Ischemia-Reperfusion Unit, Institut d'Investigacions Biomèdiques de Barcelona (IIBB), Spanish National Research Council (CSIC), 08036 Barcelona, Catalonia, Spain. jrcbam@iibb.csic.es.
Consejo Superior de Investigaciones Científicas · ESHôpital Paul-Brousse · FRUniversitat de Barcelona · ESUniversity of Coimbra · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Institut George Lopez-1 (IGL-1) and Histidine-tryptophan-ketoglutarate (HTK) solutions are proposed as alternatives to UW (gold standard) in liver preservation. Their composition differs in terms of the presence/absence of oncotic agents such as HES or PEG, and is decisive for graft conservation before transplantation. This is especially so when fatty (steatotic) livers are used since these grafts are more vulnerable to ischemia insult during conservation. Their composition determines the extent of the subsequent reperfusion injury after transplantation. Aldehyde dehydrogenase-2 (ALDH2), a mitochondrial enzyme, has been reported to play a protective role in warm ischemia-reperfusion injury (IRI), but its potential in fatty liver cold ischemic injury has not yet been investigated. We evaluated the relevance of ALDH2 activity in cold ischemia injury when fatty liver grafts from Zucker Obese rats were preserved in UW, HTK, and IGL-1 solutions, in order to study the mechanisms involved. ALDH2 upregulation was highest in livers preserved in IGL-1. It was accompanied by a decrease in transaminases, apoptosis (Caspase 3 and TUNEL assay), and lipoperoxidation, which was concomitant with the effective clearance of toxic aldehydes such as 4-hydroxy-nonenal. Variations in ATP levels were also determined. The results were consistent with levels of NF-E2 p45-related factor 2 (Nrf2), an antioxidant factor. Here we report for the first time the relevance of mitochondrial ALDH2 in fatty liver cold preservation and suggest that ALDH2 could be considered a potential therapeutic target or regulator in clinical transplantation.

Indexed as

Cold IschemiaAldehyde Dehydrogenase, MitochondrialAnimalsApoptosisBiomarkersCryopreservationFatty LiverLiver TransplantationMitochondriaOrgan PreservationOrgan Preservation SolutionsRatsReactive Oxygen SpeciesReperfusion InjuryTime FactorsAldehyde Dehydrogenase, MitochondrialAldh2 protein, ratBiomarkersOrgan Preservation SolutionsReactive Oxygen Species4-hydroxynonenal (4-HNE)ALDH2apoptosiscaspases 3HTKIGL-1MDAUW

Identifiers

PMID30131474
PMCPMC6164398
OpenAlexW2888443339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.